Home / Letter From The Editor / Jan. 5, 2019

Jan. 5, 2019

Jan 5, 2019
 

My wife is heading in to her first appointment with an endocrinologist. After 3 years of controlling her glucose with long acting insulin, a GLP-1 analog and an SGLT-2I, she had to go on meal time insulin. The use of meal time insulin forced her to check her glucose more often and she found glucose swings with no explanation. One of the first things that frustrated her was the effect exercising had on her glucose. On multiple days she would be great before breakfast and regardless of what she tried after her morning bike ride, her glucose would often go to 300mg/dl. This happened with little regard to her food choices.

Her main goal of the appointment is to get a CGM device. Based on her checking her glucose 6-8 times a day and injecting insulin as often, having a CGM device would definitely be warranted.

But what about our patients that don’t need to be as intensively managed; will they be candidates for CGM? This week our good friend, David Kliff, joins us with a special feature on the use of CGM devices in these less intensive patients. The nice thing about Dave’s commentary is his perspective. He is both a patient who has insulin dependent diabetes and a financial guru. His focus in the article is on the practicality of patients requiring less intensive management using CGM, and what the devices and protocols would look like. Check out item #6 to take you to the page.

And be sure to also check out the results of our exclusive survey on what patients and healthcare professionals think about insulin pumps vs smart pens vs multiple daily injections in item #1.

*****************************

We can make a difference!

*****************************

Dave Joffe

Editor-in-chief